hey sleepyhead, I saw on contrarian you were talking about the SCTY lockup expiration.
You have the information correct, the 90 day lockup from oct 15 for the executives is monday, jan 13th. This is trivial because the executives have very few shares. However, the 51 m shares don't have lockup expiration until 120 days because those are "other investors", so i guess that's 30 days from jan 13th.
You can find the relevant information on page 41 and 82 of the following document:
http://www.sec.gov/Archives/edgar/data/1408356/000119312513399784/d553628ds1a.htm
Upon completion of this offering and the concurrent offering of 3,400,000 shares of common stock, we will have 81,678,355 outstanding shares of common stock
24,836,844 shares will be eligible for sale immediately upon completion of these offerings;
50,594,568 shares will become eligible for sale upon the expiration of the “lock-up” agreements described under “Underwriting” below, subject to the provisions of Rule 144 or Rule 701 under the Securities Act, as well as our insider trading policy;
AND HERE IS THE LOCKUP, BOLDED BELOW, FROM OCTOBER 15th.... 90 DAYS FROM THEN IS 1/13/2014:
We, our directors and executive officers, and funds affiliated with Draper Fisher Jurvetson, DBL Investors, AJG Growth Fund, Valor VC, LLC and Valor Solar Holding, LLC have agreed, during the period beginning the date hereof and continuing until, with respect to us and a group of “specified executive officers” consisting of our executive officers other than our chief executive officer, chief operating officer/chief technology officer and chief financial officer, until the date 90 days after the date of this prospectus, and with respect to the other stockholders agreeing to a lock-up, until the date 120 days after the date of this prospectus, and subject to limited exceptions, not to offer, sell, contract to sell or
82
otherwise dispose of any shares of common stock, any securities substantially similar to the notes or the common stock or any securities convertible, exchangeable or exercisable for common stock or substantially similar securities, without the prior written consent of the Representatives.